Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models

[1]  L. Qiu,et al.  A preliminary study , 2018, Medicine.

[2]  Pei-Wen Wang,et al.  Elucidating the Skin Delivery of Aglycone and Glycoside Flavonoids: How the Structures Affect Cutaneous Absorption , 2017, Nutrients.

[3]  B. Blough,et al.  Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride. , 2017, International journal of pharmaceutics.

[4]  H. Lev-Tov.  How Microneedles Can Change Cutaneous Drug Delivery-Small Needles Make a Big Difference. , 2017, JAMA dermatology.

[5]  U. Blume-Peytavi,et al.  Assessment of skin barrier function and biochemical changes of ex vivo human skin in response to physical and chemical barrier disruption , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  Y. Hiruta,et al.  Transcutaneous drug delivery by liposomes using fractional laser technology , 2017, Lasers in surgery and medicine.

[7]  M. Calderón,et al.  Drug delivery across intact and disrupted skin barrier: Identification of cell populations interacting with penetrated thermoresponsive nanogels , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  K. Ita.  Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  T. Vos,et al.  Global Skin Disease Morbidity and Mortality , 2017, JAMA dermatology.

[10]  Kwang-Hyeon Liu,et al.  As in Atopic Dermatitis, Nonlesional Skin in Allergic Contact Dermatitis Displays Abnormalities in Barrier Function and Ceramide Content. , 2017, The Journal of investigative dermatology.

[11]  D. Miklavčič,et al.  The effect of pulse duration, power and energy of fractional Er:YAG laser for transdermal delivery of differently sized FITC dextrans. , 2017, International journal of pharmaceutics.

[12]  A. Lamprecht,et al.  In vivo skin penetration of macromolecules in irritant contact dermatitis. , 2016, International journal of pharmaceutics.

[13]  S. S. Ganti,et al.  Non-Ablative Fractional Laser to Facilitate Transdermal Delivery. , 2016, Journal of pharmaceutical sciences.

[14]  S. Shen,et al.  Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  Mei X. Wu,et al.  Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Jhi-Joung Wang,et al.  Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: The skin absorption assessment. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  C. Janfelt,et al.  Fractional laser‐assisted drug delivery: Laser channel depth influences biodistribution and skin deposition of methotrexate , 2016, Lasers in surgery and medicine.

[18]  H. Drexler,et al.  Influence of artificial sebum on the dermal absorption of chemicals in excised human skin: A proof-of-concept study. , 2016, Toxicology in vitro : an international journal published in association with BIBRA.

[19]  Chih-Hung Lee,et al.  What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model. , 2016, International journal of pharmaceutics.

[20]  F. Hölzle,et al.  Effects of non-ablative fractional erbium glass laser treatment on gene regulation in human three-dimensional skin models , 2016, Lasers in Medical Science.

[21]  M. Sugaya,et al.  Recent advances in atopic dermatitis and psoriasis: genetic background, barrier function, and therapeutic targets. , 2015, Journal of dermatological science.

[22]  Chi‐Kuang Sun,et al.  Fractional Thermolysis by Bipolar Radiofrequency Facilitates Cutaneous Delivery of Peptide and siRNA with Minor Loss of Barrier Function , 2015, Pharmaceutical Research.

[23]  C. Hung,et al.  Skin aging modulates percutaneous drug absorption: the impact of ultraviolet irradiation and ovariectomy , 2015, AGE.

[24]  J. Krueger,et al.  The translational revolution and use of biologics in patients with inflammatory skin diseases. , 2015, The Journal of allergy and clinical immunology.

[25]  R. Hickerson,et al.  In vivo gene silencing following non-invasive siRNA delivery into the skin using a novel topical formulation , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[26]  S. Shen,et al.  Erbium-yttrium-aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs. , 2014, Journal of pharmaceutical sciences.

[27]  C. Sung,et al.  Squarticles as a Lipid Nanocarrier for Delivering Diphencyprone and Minoxidil to Hair Follicles and Human Dermal Papilla Cells , 2014, The AAPS Journal.

[28]  Dieter Manstein,et al.  Micro-fractional epidermal powder delivery for improved skin vaccination. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[29]  R. Neubert,et al.  Skin Diseases Associated with the Depletion of Stratum Corneum Lipids and Stratum Corneum Lipid Substitution Therapy , 2014, Skin Pharmacology and Physiology.

[30]  J. Bouwstra,et al.  TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. , 2014, The Journal of investigative dermatology.

[31]  M. Shin,et al.  Nonablative fractional laser as a tool to facilitate skin penetration of 5‐aminolaevulinic acid with minimal skin disruption: a preliminary study , 2014, The British journal of dermatology.

[32]  S. Shen,et al.  Noninvasive delivery of siRNA and plasmid DNA into skin by fractional ablation: erbium:YAG laser versus CO₂ laser. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  I. Aljuffali,et al.  Lasers as an approach for promoting drug delivery via skin , 2014, Expert opinion on drug delivery.

[34]  Hidetoshi Takahashi,et al.  Defective barrier function accompanied by structural changes of psoriatic stratum corneum , 2014, The Journal of dermatology.

[35]  S. Shen,et al.  Impact of Different Vehicles for Laser-Assisted Drug Permeation via Skin: Full-Surface versus Fractional Ablation , 2014, Pharmaceutical Research.

[36]  J. Lademann,et al.  Drug delivery to hair follicles , 2013, Expert opinion on drug delivery.

[37]  Hung-Hsu Yang,et al.  Skin Permeation of Small-Molecule Drugs, Macromolecules, and Nanoparticles Mediated by a Fractional Carbon Dioxide Laser: The Role of Hair Follicles , 2013, Pharmaceutical Research.

[38]  Reinhold H Dauskardt,et al.  Solar UV radiation reduces the barrier function of human skin , 2012, Proceedings of the National Academy of Sciences.

[39]  Y. Kalia,et al.  Transcutaneous vaccination via laser microporation , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[40]  R. Guy,et al.  Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Ramsey F Markus,et al.  Current Laser Resurfacing Technologies: A Review that Delves Beneath the Surface , 2012, Seminars in Plastic Surgery.

[42]  M. Prausnitz,et al.  Transdermal Insulin Delivery Using Microdermabrasion , 2011, Pharmaceutical Research.

[43]  T. Maisch,et al.  Penetration enhancement of two topical 5‐aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation , 2010, Experimental dermatology.

[44]  H. Maibach,et al.  Enhanced Absorption through Damaged Skin: An Overview of the in vitro Human Model , 2010, Skin Pharmacology and Physiology.

[45]  L. Boon,et al.  Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.

[46]  Chun-Ming Huang,et al.  Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[47]  B. Berne,et al.  Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. , 2008, The Journal of investigative dermatology.

[48]  Carien M Niessen,et al.  Tight junctions/adherens junctions: basic structure and function. , 2007, The Journal of investigative dermatology.

[49]  M. Yáñez-Mó,et al.  Differential expression of activation epitopes of beta1 integrins in psoriasis and normal skin. , 1998, The Journal of investigative dermatology.

[50]  J. Brandner,et al.  Tight junctions in skin inflammation , 2016, Pflügers Archiv - European Journal of Physiology.

[51]  I. Aljuffali,et al.  Skin ablation by physical techniques for enhancing dermal/transdermal drug delivery , 2014 .

[52]  M. Marinkovich,et al.  Role of dermal-epidermal basement membrane zone in skin, cancer, and developmental disorders. , 2010, Dermatologic clinics.